CCM
GMED icon

Coldstream Capital Management’s Globus Medical GMED Stock Holding History

Coldstream Capital Management’s Portfolio GMED Stock Details GMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$435K Sell
5,505
-365
-6% -$31K 0.01% 802
2026
Q1 		$506K Buy
5,870
+1,392
+31% +$125K 0.01% 723
2025
Q4 		$391K Sell
4,478
-1,822
-29% -$138K 0.01% 807
2025
Q3 		$361K Sell
6,300
-755
-11% -$43.5K ﹤0.01% 858
2025
Q2 		$416K Sell
7,055
-294
-4% -$19K 0.01% 739
2025
Q1 		$538K Buy
7,349
+272
+4% +$22.5K 0.01% 573
2024
Q4 		$585K Buy
7,077
+858
+14% +$67.7K 0.01% 540
2024
Q3 		$447K Buy
6,219
+131
+2% +$9.25K 0.01% 655
2024
Q2 		$417K Sell
6,088
-64
-1% -$3.82K 0.01% 619
2024
Q1 		$330K Buy
6,152
+82
+1% +$4.41K 0.01% 727
2023
Q4 		$323K Buy
6,070
+1,939
+47% +$94.5K 0.01% 675
2023
Q3 		$205K Buy
+4,131
New +$231K 0.01% 754
2023
Q1 		– Sell
-3,252
Closed -$242K – 845
2022
Q4 		$242K Buy
+3,252
New +$221K 0.01% 700
2022
Q1 		– Sell
-3,058
Closed -$221K – 806
2021
Q4 		$221K Buy
+3,058
New +$222K 0.01% 755

Other funds holding GMED

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
SC
Sculptor Capital New York $12.3B AUM 40.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Coldstream Capital Management's GMED Position: Q2 2026 in Review

Coldstream Capital Management reduced its Globus Medical (GMED) stake by 6.2% in Q2 2026, selling an estimated $31K and leaving 5,505 shares worth $435K. The position accounts for 0.01% of the portfolio, ranked #802.

Coldstream Capital Management first reported a position in GMED in Q4 2021 and has held it in 14 quarters since. The position peaked at $585K in Q4 2024. 599 funds tracked by Wall St. Rank hold GMED as of Q2 2026.

  • Coldstream Capital Management held 5,505 shares of Globus Medical worth $435K as of Q2 2026.
  • Coldstream Capital Management sold 365 Globus Medical shares in Q2 2026, an estimated $31K.
  • Globus Medical made up 0.01% of Coldstream Capital Management's portfolio in Q2 2026, its #802 holding.
  • Coldstream Capital Management first reported a position in Globus Medical in Q4 2021 and has held it in 14 quarters since.
  • Coldstream Capital Management's Globus Medical position peaked at $585K in Q4 2024.
  • 599 funds tracked by Wall St. Rank held Globus Medical as of Q2 2026.

Based on Coldstream Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.